Oppenheimer Reiterates Harmony Biosciences Holdings (HRMY) Outperform Recommendation
27/5 01:19
Fintel reports that on May 26, 2023, Oppenheimer reiterated coverage of Harmony Biosciences Holdings (NASDAQ:HRMY) with a Outperform recommendation....
|
|
|
27/5 01:19
Fintel reports that on May 26, 2023, Oppenheimer reiterated coverage of Harmony Biosciences Holdings (NASDAQ:HRMY) with a Outperform recommendation....